Literature DB >> 10403155

On the validity of the Bech-Rafaelsen Melancholia Scale (BRMS).

M Smolka1, R D Stieglitz.   

Abstract

BACKGROUND: The findings published to date on convergent validity of the BRMS are mainly concerned with the correlation with other observer-rating scales for depression. In many studies on the evaluation of therapeutic interventions self-rating scales are used in connection with observer-rating scales. Therefore, findings on the relations among instruments of both groups are necessary in order to justify the combination of a particular observer-rating scale with a particular self-rating scale. In the ICD-10 three different degrees of severity of depressive episodes are distinguished. No data on the discriminant validity of the BRMS with respect to this new diagnostic classification are available till now.
METHODS: 45 depressed inpatients were assessed with two observer-rating scales (BRMS and DEPRES of the AMDP system) and two self-rating scales (BDI and DS).
RESULTS: The discriminant validity with reference to the three degrees of severity of depressive episodes as defined in ICD-10 is at r = 0.80 very high. The convergent validity of the BRMS is high at r = 0.70, related to the DEPRES. The correlations between the BRMS and the BDI as well as the DS were clearly lower, at 0.53 and 0.32 each.
CONCLUSIONS: The only moderate convergent validity between self-rating and observer-rating scales is a strong argument for a multi-methodological approach in the context of therapy evaluation.

Entities:  

Mesh:

Year:  1999        PMID: 10403155     DOI: 10.1016/s0165-0327(98)00150-5

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  3 in total

Review 1.  The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: a 20-year review of its use as an outcome measure.

Authors:  Per Bech
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  The Greek translation of the symptoms rating scale for depression and anxiety: preliminary results of the validation study.

Authors:  Konstantinos N Fountoulakis; Apostolos Iacovides; Soula Kleanthous; Stavros Samolis; Kyriakos Gougoulias; George St Kaprinis; Per Bech
Journal:  BMC Psychiatry       Date:  2003-12-10       Impact factor: 3.630

Review 3.  Comprehensive Psychopathological Assessment Based on the Association for Methodology and Documentation in Psychiatry (AMDP) System: Development, Methodological Foundation, Application in Clinical Routine, and Research.

Authors:  Rolf-Dieter Stieglitz; Achim Haug; Erdmann Fähndrich; Michael Rösler; Wolfgang Trabert
Journal:  Front Psychiatry       Date:  2017-04-07       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.